The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease
Annals of Clinical and Translational Neurology · 30.10.2026
DOI: 10.1002/acn3.70558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 30.10.2026. Verfasst von Fausto Roveta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience "Rita Levi-Montalcini", University of Turin, Turin, Italy. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State of Geneva, Private Foundation of Geneva University Hospitals, Association Suisse pour la Recherche sur la Maladie d'Alzheimer (A.P.R.A.).
Themen: Demenz
Abstract (Originalsprache)
Objective
To clarify the relative contributions of amyloid and tau to synaptic dysfunction in Alzheimer's disease (AD).
Methods
We included 109 cognitively unimpaired and impaired individuals from the Geneva Memory Center with available CSF synaptic biomarkers (neurogranin, SNAP‐25, GAP‐43). Participants were stratified according to amyloid (A) and tau (T) status, and group comparisons and correlations between synaptic and AD biomarkers were assessed. Multiple linear regression models evaluated the independent associations of amyloid and tau with synaptic markers: Model I ( n = 109) included CSF Aβ42 and p‐tau181, while Model II ( n = 69) included amyloid PET centiloid and CSF p‐tau181. Mediation analyses were performed to further investigate these relationships. Findings were replicated in the ADNI cohort ( n = 787).
Results
Synaptic biomarker levels were significantly higher in A+/T+ individuals compared with A−/T− and A+/T− groups ( p < 0.001). CSF p‐tau181 strongly correlated with synaptic markers. In Model I, GAP43 was positively associated with both CSF Aβ42 ( β = 0.31, 95% CI 0.23–0.40) and p‐tau181 ( β = 0.94, 95% CI 0.84–1.04; p < 0.001). In Model II, lower amyloid PET centiloid ( β = −0.31, 95% CI −0.46 to −0.16) and higher p‐tau181 ( β = 1.02, 95% CI 0.86–1.19) predicted increased GAP43 ( p < 0.001), with the same pattern of associations observed for neurogranin and SNAP‐25. The association between amyloid burden and synaptic biomarkers was largely indirect, statistically mediated by CSF p‐tau181. Results were replicated in ADNI.
Interpretation
Tau pathology showed strong associations with synaptic biomarkers, with a potential mediating role in the association between amyloid pathology and synaptic dysfunction. These findings support a central role of tau‐related processes in synaptic dysfunction in AD.
Autor:innen und Institutionen
- Department of Neuroscience "Rita Levi-Montalcini", University of Turin, Turin, Italy.
- Geneva Memory Center, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.
- Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
- Division of Nuclear Medicine and Molecular Imaging, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland.
- Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocenter and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
- CIBM Center for Biomedical Imaging, Geneva, Switzerland.
ORCID-Profile: Fausto Roveta, Federica Ribaldi
Förderung
- State of Geneva
- Private Foundation of Geneva University Hospitals
- Association Suisse pour la Recherche sur la Maladie d'Alzheimer (A.P.R.A.)
- Fondation Segré
- Race Against Dementia Foundation
- Fondation Child Care
- Fondation Edmond J. Safra
- Fondation Minkoff
Zitieren
APA
Roveta, F., Mendes, A. J., Garibotto, V., Boccalini, C., Lathuiliere, A., Rainero, I., Rubino, E., Zetterberg, H., Ashton, N. J., Ribaldi, F., Frisoni, G. B., & Alzheimer's Disease Neuroimaging Initiative (2026). The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70558
Vancouver
Roveta F, Mendes AJ, Garibotto V, Boccalini C, Lathuiliere A, Rainero I, et al. The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70558
BibTeX
@article{Roveta2026,
author = {Roveta, Fausto and Mendes, Augusto J and Garibotto, Valentina and Boccalini, Cecilia and Lathuiliere, Aurelien and Rainero, Innocenzo and Rubino, Elisa and Zetterberg, Henrik and Ashton, Nicholas J and Ribaldi, Federica and Frisoni, Giovanni B and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70558}
}
EUVIMED